Your browser doesn't support javascript.
loading
The multi-factorial nature of clinical multidrug resistance in cancer.
Assaraf, Yehuda G; Brozovic, Anamaria; Gonçalves, Ana Cristina; Jurkovicova, Dana; Line, Aija; Machuqueiro, Miguel; Saponara, Simona; Sarmento-Ribeiro, Ana Bela; Xavier, Cristina P R; Vasconcelos, M Helena.
Afiliación
  • Assaraf YG; The Fred Wyszkowski Cancer Research Laboratory, Department of Biology, Technion-Israel Institute of Technology, Haifa, 3200000, Israel. Electronic address: assaraf@technion.ac.il.
  • Brozovic A; Division of Molecular Biology, Ruder Boskovic Institute, Bijenicka cesta 54, 10000, Zagreb, Croatia.
  • Gonçalves AC; Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology, Faculty of Medicine, University of Coimbra, FMUC, Coimbra, Portugal; Coimbra Institute for Clinical and Biomedical Research (iCBR) - Group of Environment Genetics and Oncobiology (CIMAGO), FMUC, Coimbra, Portugal; Ce
  • Jurkovicova D; Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Line A; Latvian Biomedical Research and Study Centre, Riga, Latvia.
  • Machuqueiro M; BioISI-Biosystems & Integrative Sciences Institute, Faculty of Sciences, University of Lisboa, C8 Building, Campo Grande, 1749-016, Lisboa, Portugal; Departamento de Química e Bioquímica, Centro de Química e Bioquímica, Faculdade de Ciências da Universidade de Lisboa, Campo Grande, 1749-016, Lis
  • Saponara S; Department of Life Sciences, University of Siena, Siena, Italy.
  • Sarmento-Ribeiro AB; Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology, Faculty of Medicine, University of Coimbra, FMUC, Coimbra, Portugal; Coimbra Institute for Clinical and Biomedical Research (iCBR) - Group of Environment Genetics and Oncobiology (CIMAGO), FMUC, Coimbra, Portugal; Ce
  • Xavier CPR; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal.
  • Vasconcelos MH; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal; Department of Biological Sciences, FFUP - Faculty of Pharmacy of the Univ
Drug Resist Updat ; 46: 100645, 2019 09.
Article en En | MEDLINE | ID: mdl-31585396
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a Múltiples Medicamentos / Resistencia a Antineoplásicos / Neoplasias Límite: Humans Idioma: En Revista: Drug Resist Updat Asunto de la revista: ANTINEOPLASICOS Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Resistencia a Múltiples Medicamentos / Resistencia a Antineoplásicos / Neoplasias Límite: Humans Idioma: En Revista: Drug Resist Updat Asunto de la revista: ANTINEOPLASICOS Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido